Contrast-enhanced ultrasound of peripheral lymph nodes

k 2010

Contrast-enhanced ultrasound of peripheral lymph nodes

JAKUBCOVÁ, Radka, Jakub FOUKAL, Karel BENDA, Eva BUDINSKÁ, Mojmír MOULIS et. al.

Základní údaje

Originální název

Contrast-enhanced ultrasound of peripheral lymph nodes

Autoři

JAKUBCOVÁ, Radka (203 Česká republika, garant, domácí), Jakub FOUKAL (203 Česká republika, domácí), Karel BENDA (203 Česká republika, domácí), Eva BUDINSKÁ (703 Slovensko, domácí), Mojmír MOULIS (203 Česká republika, domácí) a David ŠÁLEK (203 Česká republika)

Vydání

European Congress of Radiology, Vienna, Austria, 2010

Další údaje

Jazyk

angličtina

Typ výsledku

Prezentace na konferencích

Obor

30000 3. Medical and Health Sciences

Stát vydavatele

Česká republika

Utajení

není předmětem státního či obchodního tajemství

Odkazy

DOI: 10.1594/ecr2010/C-2442

Kód RIV

RIV/00216224:14110/10:00051349

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1594/ecr2010/C-2442

Klíčová slova anglicky

sulphur hexafluoride; ultrasound; lymphadenopathy

Změněno: 17. 1. 2012 12:18, MUDr. Radka Šlaisová, Ph.D.

Anotace

V originále

Purpose: To evaluate the benefit of contrast-enhanced ultrasound compared to colour Doppler ultrasound in distinction between benign and malignant lymph nodes in pacients with peripheral lymphadenopathy. Methods and materials: Total number of 80 patients were examined (29 women, 51 men, age 22-86 years). Examinations were performed on Philips iU22 ultrasound machine using 17MHz probe natively for evaluation of pattern of node’s vascularization and 9MHz probe for evaluation of pattern of enhancement with 1,5 ml intravenous bolus of sulphur hexafluoride contrast agent (SonoVue, Bracco, Italy) using power modulation mode with mechanical index 0.04. According to the pattern of vascularization and enhancement the nodes were divided into group of benign and malignant ones. All nodes were extirpated, ultrasound and histological findings were correlated. Results: Total number of 84 lymph nodes were extirpated, 26 benign (30,9%) and 58 malignant (69,1%). Except for 4 nodes (4,8%) with hyperechoic center all nodes were hypoechoic. 8 nodes (9,5%) had no Doppler signal. According to ROC analysis senzitivity in comparison with native ultrasound examination increased from 77,6% to 98,3%, but specificity decreased from 84,6% to 80,4%. Overall accuracy of the method increased from 76,9% to 89,5%. Mann-Whitney U test confirmed larger maximum size of malignant nodes (p=0,024) and lower LT ratio (p<0,001). Metastasis and lymphoproliferative disorded could have been distinguished in case of malignant lymphadenopathy Conclusion: Contrast-enhanced ultrasound can detect changes in normal structure of a lymph node. Signs of malignancy are heterogeneous enhancement with peripheral rim, unenhancing center, areas of necrosis and postcontrast wash-out.

Citovat

JAKUBCOVÁ, Radka, Jakub FOUKAL, Karel BENDA, Eva BUDINSKÁ, Mojmír MOULIS a David ŠÁLEK. Contrast-enhanced ultrasound of peripheral lymph nodes. In European Congress of Radiology, Vienna, Austria. 2010. Dostupné z: https://dx.doi.org/10.1594/ecr2010/C-2442.

@proceedings{881361,
   author = {Jakubcová, Radka and Foukal, Jakub and Benda, Karel and Budinská, Eva and Moulis, Mojmír and Šálek, David},
   booktitle = {European Congress of Radiology, Vienna, Austria},
   doi = {http://dx.doi.org/10.1594/ecr2010/C-2442},
   keywords = {sulphur hexafluoride; ultrasound; lymphadenopathy},
   language = {eng},
   title = {Contrast-enhanced ultrasound of peripheral lymph nodes},
   url = {http://www.doi.org},
   year = {2010}
}

TY  - CONF
ID  - 881361
AU  - Jakubcová, Radka - Foukal, Jakub - Benda, Karel - Budinská, Eva - Moulis, Mojmír - Šálek, David
PY  - 2010
TI  - Contrast-enhanced ultrasound of peripheral lymph nodes
KW  - sulphur hexafluoride
KW  - ultrasound
KW  - lymphadenopathy
UR  - http://www.doi.org
N2  - Purpose: To evaluate the benefit of contrast-enhanced ultrasound compared to colour Doppler ultrasound in distinction between benign and malignant lymph nodes in pacients with peripheral lymphadenopathy. Methods and materials: Total number of 80 patients were examined (29 women, 51 men, age 22-86 years). Examinations were performed on Philips iU22 ultrasound machine using 17MHz probe natively for evaluation of pattern of node’s vascularization and 9MHz probe for evaluation of pattern of enhancement with 1,5 ml intravenous bolus of sulphur hexafluoride contrast agent (SonoVue, Bracco, Italy) using power modulation mode with mechanical index 0.04. According to the pattern of vascularization and enhancement the nodes were divided into group of benign and malignant ones. All nodes were extirpated, ultrasound and histological findings were correlated. Results: Total number of 84 lymph nodes were extirpated, 26 benign (30,9%) and 58 malignant (69,1%). Except for 4 nodes (4,8%) with hyperechoic center all nodes were hypoechoic. 8 nodes (9,5%) had no Doppler signal. According to ROC analysis senzitivity in comparison with native ultrasound examination increased from 77,6% to 98,3%, but specificity decreased from 84,6% to 80,4%. Overall accuracy of the method increased from 76,9% to 89,5%. Mann-Whitney U test confirmed larger maximum size of malignant nodes (p=0,024) and lower LT ratio (p<0,001). Metastasis and lymphoproliferative disorded could have been distinguished in case of malignant lymphadenopathy Conclusion: Contrast-enhanced ultrasound can detect changes in normal structure of a lymph node. Signs of malignancy are heterogeneous enhancement with peripheral rim, unenhancing center, areas of necrosis and postcontrast wash-out.
ER  -

JAKUBCOVÁ, Radka, Jakub FOUKAL, Karel BENDA, Eva BUDINSKÁ, Mojmír MOULIS a David ŠÁLEK. Contrast-enhanced ultrasound of peripheral lymph nodes. In \textit{European Congress of Radiology, Vienna, Austria}. 2010. Dostupné z: https://dx.doi.org/10.1594/ecr2010/C-2442.

Podrobný výpis o publikaci